The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson's disease psychosis: a 16-week, single-arm, open-label study.

Ther Adv Neurol Disord · 2024 · PMC10929044 · PMID 38476466

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

Numeric improvement was observed in the Schwab and England ADL score, although it did not reach statistical significance [3.4 [2.97], n = 22; 95% CI (−2.7, 9.5); p > 0.05] ( Figure 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.